 Swiss drugmaker Novartis announces 5.65bn euros ($7.4bn; Â£3.9bn) of purchases to make its Sandoz unit the world's biggest generic drug producer . Sandoz will overtake Israel's Teva Pharmaceuticals as the biggest maker of generics . Novartes' shares rose 1% to 57.85 Swiss francs in early trading on Monday . Generic drugs are chemically identical to their more expensive branded rivals . There are more than 150 generic drugmakers worldwide and analysts have predicted consolidation .